2005 All Hands Meeting Science of the Mouse models of human neurodegenerative disease.

Slides:



Advertisements
Similar presentations
MOTOR NEURON DISEASE The motor neuron diseases (or motor neuron diseases) (MND) are a group of neurological disorders that selectively affect motor neurons.
Advertisements

Alzheimer’s Disease Edwin Onattu P. 3.
Demyelinating Diseases. Demyelination is a common degenerative change in the nervous system secondary to neuronal or axonal injury, But in the group of.
2005 All Hands Meeting Multivariate assessment of a preclinical mouse model of Parkinson’s disease: “Connecting the dots” to the human disease state Diana.
Degenerative Myelopathy Copyright University of Florida 1998 Of German Shepherd Dogs A chronic, progressive neurodegenerative disease Initial signs are.
MCB 135K: Discussion March 2, General Info Mid-Term I: –Avg 87 –Std. Deviation 10 –Re-grades by next Wednesday Include a cover sheet that addresses.
SCHOOL OF INFORMATION UNIVERSITY OF MICHIGAN Biomedical Informatics Research Network.
Michael Marron, Ph.D., Director Division of Biomedical Technology National Center for Research Resources National Institutes of Health Department of Health.
 Evaluation of interaction between Vitamin D 3 and neural stem cell proliferation and differentiation in to oligodendrocyte as the myelinating cell 
Desiree Abdurrachim Morphometric analysis of the hippocampus in R6/1 HD mouse model Internship August – October 2007 Desiree Abdurrachim Supervisor: Leigh.
INTRODUCTION Mutations in Presenilin (PS) 1 and 2 cause familial Alzheimer’s Disease (AD) through undetermined mechanisms. PS’s are intramembranous aspartyl.
Comparison of Plaque Burden in Tg2576 Mice Using the Aperio and TurboScan Imaging Platforms A.J. Milici.
Degenerative brain diseases
Atlas Interoperablity I & II: progress to date, requirements gathering Session I: 8:30 – 10am Session II: 10:15 – 12pm.
FTD Family Members Study & Post Mortem Study Alyson Negreira MGH Frontotemporal Disorders Unit.
Neuromuscular Disorders Brenda P. Johnson, PhD, RN.
CHAPTER TWO CHAPTER TWO Neuroscience as a Basis for Adult Development and Aging.
Michael Marron, Ph.D., Director Division of Biomedical Technology National Center for Research Resources National Institutes of Health Department of Health.
All Hands Meeting 2003 BIRN ONTOLOGIES Session Jeffrey Grethe Amarnath Gupta Bertram Ludäscher Maryann E. Martone.
COST CM1103 Training School Structure-based drug design for diagnosis and treatment of neurological diseases Istanbul, 9-13 Sept 2013 Mirjana Babić, mag.biol.mol.
Parkinson’s Plus By: Glen Estrosos.
VIII. NEURODEGENERATIVE DISEASES. - Are disorders characterized by the cellular degeneration of subsets of neurons that typically are related by function,
Creating a community-based knowledge management framework for integrating neuroscience data via ontologies. A. Gupta 1, C. Bean 2, W. Bug 3, *C. Fennema-Notestine.
Atlas Interoperablity I & II: progress to date, requirements gathering Session I: 8:30 – 10am Session II: 10:15 – 12pm.
Mouse models in Immunology
Molecular Biology and Genetics of Amyotrophic Lateral Sclerosis Michael Sidel February 13, 2008.
BIRN Advantages in Morphometry  Standards for Data Management / Curation File Formats, Database Interfaces, User Interfaces  Uniform Acquisition and.
All Hands Meeting 2005 Morphometry BIRN - Overview - Scientific Achievements.
Copyright OpenHelix. No use or reproduction without express written consent1.
Data Integration Progress. BIRN Data Integration Framework 2. Create conceptual links to a shared ontology 1. Create multimodal databases 3. Situate the.
Where we’ve been, Where we’re going Arthur Toga Laboratory of Neuro Imaging, UCLA.
Neuroimage Analysis Center An NCRR National Resource Center Time Series MRI Core Analysis, Modeling - toward Dynamic Surrogates.
High-Performance and Grid Computing for Neuroinformatics: NIC and Cerebral Data Systems Allen D. Malony University of Oregon Professor Department of Computer.
University of California, San Diego Ontology-based annotation of multiscale imaging data: Utilizing and building the Neuroscience Information Framework.
Mouse BIRN CORE 4: Applications Background test slide.
Jorge Jovicich, Ph.D. Massachusetts General Hospital - Harvard Medical School Biomedical Informatics Research Network Overview Testbeds Morphometry BIRN.
The Mouse Bioinformatics Research Network (MBIRN) Cal Tech- Russ Jacobs Duke- G. Allan Johnson Mike Fehnel UCLA- Art Toga UCSD- Mark Ellisman Maryann Martone.
Needs and Progress: Summary Flexible, powerful, modular atlas interface, and a query gateway to multiple types of data (GeneNetwork, Barlow, Smith, CCDB,
All Hands Meeting 2003 mBIRN Scientific Session Maryann Martone October 8, 2003.
High resolution MRI at 21.1 T of the hippocampus and temporal lobe white matter in the differential classification of Alzheimer’s Disease & Diffuse Lewy.
Α-synuclein transgenic mouse models of Parkinson’s disease Michelle Maurer December 2015.
Neurobiology of Dementia Majid Barekatain, M.D., Associate Professor of Psychiatry Neuropsychiatrist Isfahan University of Medical Sciences Ordibehesht.
2005 AHM Mouse BIRN. Goals Review progress on mouse BIRN milestones Update priorities and milestones for SFN, next spring, and next fall 2006 Clarify.
Mouse BIRN AHM 2007 Mouse BIRN-related activities at NCMIR- UCSD & BIRN-CC: “What we did and what we will do. Mouse BIRN-related activities at NCMIR- UCSD.
Biomedical Informatics Research Network The BIRN Architecture: An Overview Jeffrey S. Grethe, BIRN-CC 10/9/02 BIRN All Hands Meeting 2002.
N deg - 1 Characteristics of neurons u Cytoskeletal organization u Microtubules and motors u Neuronal intermediate filaments u Neurofilaments u Peripherin,
Pathogenesis and pathology of parkinsonism
Contributions to mouse BIRN tools and resources Maryann Martone and Mark Ellisman University of California, San Diego 2008.
MBAT Mouse All Hands Meeting What is included in MBAT 1.1 (existing features…) Visualization Tool –3D atlas –Brain Graph –Label, mask volume Query.
All Hands Meeting 2004 Clinician’s Requirements for HID Query and Statistics Interface Christine Fennema-Notestine, Ph.D. David Kennedy, Ph.D.
Do Now 2/9/15 1.Describe possible causes for forgetting a memory. 2.Compare and contrast semantic and episodic memories.
Emma Hahs, Brooke Armistead, Sarah Brown, Sok Kean Khoo Department of Cell and Molecular Biology, College of Liberal Arts and Sciences, Grand Valley State.
2003 All Hands Meeting FBIRN Complete the Data Analysis  Calibration and statistics issues Assess the variability Global measures ROI measures.
Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease  C Bjartmar, J.R Wujek, B.D Trapp  Journal of.
CNS Disorders and The Dementias
A potential therapy for ALS
Presenilins: a group of novel calcium channel modulators.
Alpha-synuclein in Parkinson's disease
Parkinson’s Common neurodegenerative disorder ~10-20/1000
Figure Model contrasting the potential role of antibodies to myelin oligodendrocyte glycoprotein (MOG) or aquaporin-4 (AQP4) in opticospinal inflammationMOG-specific.
The relevance of animal models in multiple sclerosis research
Stephen L. Hauser, Jorge R. Oksenberg  Neuron 
Methods Objectives Results Conclusions References
Julius A. Steinbeck, Lorenz Studer  Neuron 
Bettina Schreiner, Melanie Greter  Cell Stem Cell 
Mark S. Forman, Virginia M-Y. Lee, John Q. Trojanowski  Neuron 
Mechanisms Underlying Inflammation in Neurodegeneration
Volume 21, Issue 1, Pages (January 2013)
Bettina Schreiner, Melanie Greter  Cell Stem Cell 
A brain-targeted, modified neurosin (kallikrein-6) reduces α-synuclein accumulation in a mouse model of multiple system atrophy 汇报人:宋雨田 IMI.
Presentation transcript:

2005 All Hands Meeting Science of the Mouse models of human neurodegenerative disease

Mouse BIRN Data Integration Framework 2. Create conceptual links to a shared ontology 1. Create multimodal databases 3. Situate the data in a common spatial framework 4. Use mediator to navigate and query across data sources

Mouse models of neurological disease  Allow us to better understand the disease mechanism and potential therapies of related human neurological disorders Use of single strain (essentially “clones”):  Different imaging modalities  Different ages or progression  Gene manipulation: strain is it’s own control  Different therapies Multiple strains and crossbreeding:  Genetics and environment  Therapeutic interactions

Mouse BIRN models  Parkinson’s  Multiple Sclerosis  Alzheimer’s

Parkinson’s Disease (  -synuclein model)  Lewy Bodies  Alpha-synuclein protein (  -SYN) aggregates  Found in several brain areas in PD  Mouse model overexpressing  -SYN PD like pathology Motor deficits  Link expression of  -SYN to behavior and structure

 -synuclein Results slide Assessment of cognitive and motor function Genetic analyses (Web QTL) Ultrastructural studies using EM Correlation of large-scale mapping of immunolabeling and MRI studies

Multiple Sclerosis (EAE model)  Inflammatory autoimmune demyelinating diseases Demyelination and axonal degeneration Limb weakness and paralysis  Experimental Autoimmune Encephalomyelitis (EAE): Induced inflammatory autoimmune disease Chronic progressive disability Differential susceptibility across strains and antigens  Examine disease progression and severity in relation to structure

EAE Results slide

Alzheimer’s Disease  Several mouse models over-express APP (A  precursor protein)  These accumulate amyloid-  (A  ) protein Aggregates into extracellular lesions (amyloid plaques) Found throughout the hippocampus and cortex Accumulation of plaques similar to human  New collaborator’s model: turn on/off mutant APP production Examine if there is recovery Time course of recovery  Great place for integration with Morph testbed

Situate data in a common spatial framework Image Processing Registration Reconstruction Coregistered Data

Designing this Framework BAMS WebQTL Spatially Coregistered Images in Database Coregistered Atlas Modules Web Based Resources Ontologies MOUSE BIRN VIEWING TOOL

Multiple Ways of Querying Data Brain Cerebellum Purkinje Cell Layer Purkinje cell neuron has a is a Spatial (Atlases) Transformations Ontologies

Progress on interoperative atlasing interface SmartAtlas SHIVA Neuroterrain Individual Mouse BIRN Atlas Tools Mouse BIRN Integrated Tool Mouse Orientation and Registration Tool (MORT)

In the last year  Cyr M, Caron MG, Johnson GA, Laakso A, (2005) Magnetic resonance imaging at microscopic resolution reveals subtle morphological changes in a mouse model of dopaminergic hyperfunction, NeuroImage, 26:83-90  Anjum A. Ali, Anders M. Dale, Alexandra Badea, G. Allan Johnson (2005) Automated Segmentation of Neuroanatomical Structures in Multispectral MR Microscopy of the Mouse Brain. NeuroImage, 27:  Price DL, Chow SK, MacLean NAB, Hakozaki H, Peltier S, Martone ME, Ellisman MH (In Press) High-Resolution Large-Scale Mosaic Imaging using Multiphoton Microscopy to Characterize Transgenic Mouse Models of Human Neurological Disorders. Neuroinformatics.  Erh-Fang L, Jacobs RE, Dinov I, Leow A, Toga A, (In Press) Standard Atlas Space for C57BL/6 Neonatal Mouse Brain. Anatomy and Embryology  MacKenzie-Graham A, Tinsley M, Shah KP, Aguilar C, Strickland LV, Boline J, Martin M, Morales L, Shattuck DW, Jacobs RE, Voskuhl RR, Toga AW, (In Progress) Cerebellar Cortical Atrophy in C57BL/6J Mice with Experimental Autoimmune Encephalomyelitis.  D.L. Price, E. Rockenstein, N.A.B. MacLean, M. Mante, V. Phung, D. Askay, E. Masliah, and M.H. Ellisman (In preparation) Increased mGluR5 immunoreactivity and behavioral deficits in transgenic mice overexpressing alpha- synuclein PUBLICATIONS IN PRESS IN PREPARATION

Summary  Create powerful intuitive infrastructure to incorporate, visualize, manage, search, analyze, and compare data  Use these tools to help characterize mouse models of neurodegenerative disease, with the goal of better understanding the disease mechanism and potential therapies  Share these technologies with the scientific community